Anti-Microbial Savior BioteQ Co., Ltd. focuses on the research and development of pharmaceutical drug products in Taiwan. The company offers PoroVance precision pore engineering and small-molecule drug discovery. Its pipeline products include FORMOSA-1117, antibacterial drug candidate; YUAN-03, antiviral drug candidate; AMS-2140, broad-spectrum antiviral drug candidate; TenTacle, ADC linker-conjugate compound. Anti-Microbial Savior BioteQ Co., Ltd. was founded in 2018 and is headquartered in Kaohsiung, Taiwan.
Frequently asked questions
What sector does Anti-Microbial Savior BioteQ Co., Ltd. (6864) operate in?
Anti-Microbial Savior BioteQ Co., Ltd. belongs to the Other sector and operates in the Biotechnology industry.
What is Anti-Microbial Savior BioteQ Co., Ltd. (6864) current stock price?
As of the latest data, Anti-Microbial Savior BioteQ Co., Ltd. stock price is NT$41.50, with a previous close of NT$41.50.
What is Anti-Microbial Savior BioteQ Co., Ltd. (6864) current market capitalization?
Anti-Microbial Savior BioteQ Co., Ltd. market cap is approximately 1.57 billion.
What is Anti-Microbial Savior BioteQ Co., Ltd. (6864) Earnings Per Share (EPS)?
The trailing EPS is -NT$2.88.
Does Anti-Microbial Savior BioteQ Co., Ltd. (6864) pay dividends?
No. Anti-Microbial Savior BioteQ Co., Ltd. does not pay a dividend.
What is Anti-Microbial Savior BioteQ Co., Ltd. (6864) beta (volatility) score?
Anti-Microbial Savior BioteQ Co., Ltd. has a beta of -0.079, indicating lower volatility than the overall market.